Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis

NCT07572383 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Interstitial Lung Disease
Pulmonary Fibrosis

Interventions

DRUG: [68Ga]CBP8
DRUG: Gadoterate Meglumine

Sponsor

Peter Caravan

Collaborators

[object Object]